BR112017027855A2 - - Google Patents
Info
- Publication number
- BR112017027855A2 BR112017027855A2 BR112017027855A BR112017027855A BR112017027855A2 BR 112017027855 A2 BR112017027855 A2 BR 112017027855A2 BR 112017027855 A BR112017027855 A BR 112017027855A BR 112017027855 A BR112017027855 A BR 112017027855A BR 112017027855 A2 BR112017027855 A2 BR 112017027855A2
- Authority
- BR
- Brazil
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Fodder In General (AREA)
- Mechanical Engineering (AREA)
- Ceramic Engineering (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15173454 | 2015-06-23 | ||
| EP15173454.8 | 2015-06-23 | ||
| PCT/EP2016/064449 WO2016207234A1 (en) | 2015-06-23 | 2016-06-22 | Isoxazoline solution containing vitamin e for use with sanitized drinking water |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112017027855A2 true BR112017027855A2 (https=) | 2018-08-21 |
| BR112017027855B1 BR112017027855B1 (pt) | 2022-11-16 |
Family
ID=53488226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017027855-3A BR112017027855B1 (pt) | 2015-06-23 | 2016-06-22 | Composição farmacêutica, seu uso, água potável medicamentosa e método para sua preparação |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20180169073A1 (https=) |
| EP (1) | EP3313400B1 (https=) |
| JP (1) | JP6933983B2 (https=) |
| CN (1) | CN107750159B (https=) |
| BR (1) | BR112017027855B1 (https=) |
| ES (1) | ES2920394T3 (https=) |
| HU (1) | HUE059228T2 (https=) |
| MX (1) | MX383746B (https=) |
| PL (1) | PL3313400T3 (https=) |
| WO (1) | WO2016207234A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118477040A (zh) * | 2024-04-11 | 2024-08-13 | 河北威远药业有限公司 | 一种氟雷拉纳溶液的制备方法 |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016022066A1 (en) | 2014-08-04 | 2016-02-11 | Jerry Tan Eye Surgery Pte Ltd | Pharmaceutical compositions for demodex related blepharitis and eyelid crusting |
| KR102668200B1 (ko) * | 2015-10-28 | 2024-05-23 | 주식회사유한양행 | 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물 |
| UY40429A (es) | 2016-02-24 | 2023-10-13 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
| AU2018385766B2 (en) | 2017-12-15 | 2022-12-01 | Tarsus Pharmaceuticals, Inc. | Isoxazoline parasiticide formulations and methods for treating blepharitis |
| US12502377B2 (en) | 2019-04-04 | 2025-12-23 | Tarsus Pharmaceuticals, Inc. | Method of eradicating ticks that attach to humans using lotilaner formulations |
| CA3164924A1 (en) | 2019-12-18 | 2021-06-24 | Elanco Tiergesundheit Ag | Isoxazoline derivatives as pesticides |
| AU2021311722A1 (en) | 2020-07-24 | 2023-02-02 | Elanco Us Inc. | Process for making an isoxazoline compound and intermediate thereof |
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
| KR20230162001A (ko) * | 2021-03-11 | 2023-11-28 | 인 더 보울 애니멀 헬스, 인크. | 갯과에서 진드기 감염을 방제하기 위한 경구용 갯과 사료 및 방법 |
| CN114306231B (zh) * | 2021-12-29 | 2023-03-24 | 天津市中升挑战生物科技有限公司 | 一种氟雷拉纳杀虫剂及其制备方法和应用 |
| CN115266988A (zh) * | 2022-08-01 | 2022-11-01 | 江苏慧聚药业股份有限公司 | 一种氟雷拉钠有关物质的检测方法 |
| CN117064851B (zh) * | 2023-09-20 | 2026-02-17 | 中国农业大学 | 一种异噁唑啉类驱虫药制剂的制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962488A (en) * | 1998-04-08 | 1999-10-05 | Roberts Laboratories, Inc. | Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives |
| ATE473944T1 (de) * | 2000-06-27 | 2010-07-15 | Procter & Gamble | Mittel zur wasserbehandlung |
| US20050005868A1 (en) * | 2003-07-11 | 2005-01-13 | Shepard Allan T. | Animal drinking water production |
| AU2005219788B2 (en) | 2004-03-05 | 2010-06-03 | Nissan Chemical Corporation | Isoxazoline-substituted benzamide compound and noxious organism control agent |
| TWI412322B (zh) | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
| JP2007319124A (ja) * | 2006-06-02 | 2007-12-13 | Nippon Tablet Kk | 健康食品 |
| US8372867B2 (en) | 2007-04-10 | 2013-02-12 | Bayer Cropscience Ag | Insecticidal aryl isoxazoline derivatives |
| TWI430995B (zh) | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
| ES2549731T3 (es) | 2007-06-27 | 2015-11-02 | E. I. Du Pont De Nemours And Company | Método para el control de plagas en animales |
| US20090024541A1 (en) * | 2007-07-20 | 2009-01-22 | Gary Kremen | Power purchase methods, agreements and financial instruments for tax-advantaged financing residential renewable energy equipment |
| TWI556741B (zh) * | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
| TWI411395B (zh) | 2007-12-24 | 2013-10-11 | Syngenta Participations Ag | 殺蟲化合物 |
| CN102088856B (zh) * | 2008-07-09 | 2015-11-25 | 巴斯夫欧洲公司 | 包含异*唑啉化合物的杀虫活性混合物i |
| US7951404B2 (en) | 2008-07-11 | 2011-05-31 | Sanosil Ag | Concentrate for preparing a disinfectant and methods for its preparation and use |
| ES2442342T3 (es) | 2008-12-18 | 2014-02-11 | Novartis Ag | Derivados de las isoxazolinas y su uso como pesticida |
| CA2747354C (en) | 2008-12-19 | 2016-12-06 | Novartis Ag | Isoxazoline derivatives and their use as pesticide |
| EP3078664B1 (en) | 2009-12-17 | 2019-02-20 | Merial Inc. | Antiparasitic dihydroazole compositions |
| JP2013518084A (ja) * | 2010-02-01 | 2013-05-20 | ビーエーエスエフ ソシエタス・ヨーロピア | 有害動物を駆除するための置換されたケトン性イソオキサゾリン化合物および誘導体 |
| MX2012011549A (es) | 2010-04-08 | 2013-01-29 | Ah Usa 42 Llc | Derivados de 3,5-difenil-isoxazolina sustituida como insecticidas y acaricidas. |
| WO2012155352A1 (en) | 2011-05-19 | 2012-11-22 | Eli Lilly And Company | Dihydroisoxazole compounds, parasiticidal uses and formulations thereof |
| KR20140054302A (ko) | 2011-08-25 | 2014-05-08 | 신젠타 파티서페이션즈 아게 | 살곤충 화합물로서의 이속사졸린 유도체 |
| WO2013026695A1 (en) | 2011-08-25 | 2013-02-28 | Syngenta Participations Ag | Isoxazoline derivatives as insecticidal compounds |
| PL3172964T3 (pl) * | 2011-09-12 | 2021-03-08 | Boehringer Ingelheim Animal Health USA Inc. | Kompozycje przeciwpasożytniczne zawierające izoksazolinową substancję czynną, sposób i ich zastosowania |
| CA2924537C (en) | 2013-09-30 | 2018-01-16 | Todd P. Foster | Long-acting spiro-isoxazoline formulations |
| US9371293B2 (en) | 2013-10-25 | 2016-06-21 | Sumitomo Chemical Company, Limited | Isoxazoline compound composition |
| DK3063144T3 (da) | 2013-11-01 | 2021-10-25 | Boehringer Ingelheim Animal Health Usa Inc | Antiparasitære og pesticid-isoxazolinforbindelser |
| WO2015086551A1 (en) * | 2013-12-10 | 2015-06-18 | Intervet International B.V. | Antiparasitic use of isoxazoline compounds |
| PT3082806T (pt) * | 2013-12-20 | 2021-06-04 | Intervet Int Bv | Utilização de derivados de isoxazolina para o tratamento ou a prevenção de infestações de artrópodes em aves |
| RU2688919C1 (ru) * | 2013-12-20 | 2019-05-23 | Интервет Интернэшнл Б.В. | Изоксазолиновые композиции и их применение в провилактике или лечении паразитарных инвазий животных |
| US20170354593A1 (en) * | 2014-11-03 | 2017-12-14 | Zoetis Services Llc | Palatable chewable veterinary composition |
-
2016
- 2016-06-22 HU HUE16733385A patent/HUE059228T2/hu unknown
- 2016-06-22 EP EP16733385.5A patent/EP3313400B1/en active Active
- 2016-06-22 BR BR112017027855-3A patent/BR112017027855B1/pt active IP Right Grant
- 2016-06-22 JP JP2017566402A patent/JP6933983B2/ja active Active
- 2016-06-22 PL PL16733385.5T patent/PL3313400T3/pl unknown
- 2016-06-22 CN CN201680036814.8A patent/CN107750159B/zh active Active
- 2016-06-22 ES ES16733385T patent/ES2920394T3/es active Active
- 2016-06-22 MX MX2017016671A patent/MX383746B/es unknown
- 2016-06-22 WO PCT/EP2016/064449 patent/WO2016207234A1/en not_active Ceased
- 2016-06-22 US US15/735,252 patent/US20180169073A1/en not_active Abandoned
-
2019
- 2019-07-26 US US16/523,780 patent/US11179372B2/en active Active
-
2021
- 2021-07-30 US US17/390,258 patent/US11878006B2/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118477040A (zh) * | 2024-04-11 | 2024-08-13 | 河北威远药业有限公司 | 一种氟雷拉纳溶液的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| HUE059228T2 (hu) | 2022-10-28 |
| US20190343808A1 (en) | 2019-11-14 |
| WO2016207234A1 (en) | 2016-12-29 |
| EP3313400A1 (en) | 2018-05-02 |
| CN107750159A (zh) | 2018-03-02 |
| US11179372B2 (en) | 2021-11-23 |
| CN107750159B (zh) | 2021-10-29 |
| BR112017027855B1 (pt) | 2022-11-16 |
| JP2018521995A (ja) | 2018-08-09 |
| US20210354283A1 (en) | 2021-11-18 |
| PL3313400T3 (pl) | 2022-07-25 |
| JP6933983B2 (ja) | 2021-09-08 |
| MX383746B (es) | 2025-03-14 |
| EP3313400B1 (en) | 2022-06-15 |
| MX2017016671A (es) | 2018-03-15 |
| US20180169073A1 (en) | 2018-06-21 |
| ES2920394T3 (es) | 2022-08-03 |
| US11878006B2 (en) | 2024-01-23 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/06/2016, OBSERVADAS AS CONDICOES LEGAIS |